{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial pulmonary fibrosis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_abatacept",
          "name": "Abatacept"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_anakinra",
          "name": "Anakinra"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_daclizumab",
          "name": "Daclizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_pirfenidone",
          "name": "Pirfenidone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_teriflunomide",
          "name": "Teriflunomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_abatacept",
          "type": "Drug",
          "label": "Abatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anakinra",
          "type": "Drug",
          "label": "Anakinra",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_daclizumab",
          "type": "Drug",
          "label": "Daclizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nintedanib",
          "type": "Drug",
          "label": "Nintedanib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_pirfenidone",
          "type": "Drug",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_teriflunomide",
          "type": "Drug",
          "label": "Teriflunomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_fpf",
          "type": "Disease",
          "label": "Familial pulmonary fibrosis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_abatacept",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "相关文献支持此药物禁忌用于肺纤维化"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已有报道显示此药物可能加重肺纤维化"
        },
        {
          "source": "drug_anakinra",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "针对肺纤维化潜在风险的机制推测"
        },
        {
          "source": "drug_azathioprine",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与肺纤维化历史关联性报告"
        },
        {
          "source": "drug_bosentan",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "可能影响肺纤维化症状"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "临床观察到与肺纤维化风险相关"
        },
        {
          "source": "drug_daclizumab",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "根据机制推测可能导致肺损伤"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "药理学表明与肺纤维化风险有关"
        },
        {
          "source": "drug_nintedanib",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "用于治疗可能促进肺纤维化的机制"
        },
        {
          "source": "drug_pirfenidone",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "不良反应中提及有关肺损伤"
        },
        {
          "source": "drug_rituximab",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "影响免疫系统，可能加重肺疾病"
        },
        {
          "source": "drug_teriflunomide",
          "target": "n_fpf",
          "relation": "contraindication",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "有理论依据联系肺损伤"
        },
        {
          "source": "drug_bosentan",
          "target": "drug_nintedanib",
          "relation": "inhibits",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "两者机制交叉可能增强肺纤维化风险"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "drug_methotrexate",
          "relation": "inhibits",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "制定联合用药风险评估"
        },
        {
          "source": "drug_daclizumab",
          "target": "drug_abatacept",
          "relation": "inhibits",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "同类药物机制推导可能影响"
        },
        {
          "source": "drug_azathioprine",
          "target": "drug_rituximab",
          "relation": "inhibits",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "抑制免疫相关性肺损伤的可能性"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多个药物被认为可能对家族性肺纤维化产生负面影响",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物对肺组织的影响与其机制相关，需后续研究进行验证"
    ],
    "uncertainties": [
      "各药物长期应用后是否会加重肺纤维化风险尚不明确"
    ],
    "next_focus_for_pi": [
      "是否需要进一步评估针对特定药物的临床试验数据"
    ]
  }
}